Avricore Health Inc.（AVCR.V）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · AVCR.V · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$0.53M	$4.79M	$3.49M	$1.77M	$0.12M
Cost of Revenue	$0.30M	$2.91M	$2.28M	$1.31M	$0.09M
Gross Profit	$0.24M	$1.88M	$1.20M	$0.46M	$0.03M
Gross Margin %(computed)	44.27%	39.29%	34.53%	25.83%	24.85%
Operating Expenses
R&D Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
G&A Expenses	$0.00M	$1.75M	$1.84M	$1.01M	$1.71M
Total Operating Expenses	$1.60M	$1.74M	$1.89M	$1.27M	$1.77M
Operating Income	($1.37M)	$0.14M	($0.69M)	($0.81M)	($1.75M)
Operating Margin %(computed)	-256.15%	2.91%	-19.85%	-45.80%	—
Interest Income	$0.01M	$0.00M	$0.00M	$0.01M	$0.00M
Interest Expense	$0.01M	$0.01M	$0.01M	$0.01M	$0.05M
Income Before Tax	($1.86M)	($0.67M)	($0.70M)	($0.82M)	($1.71M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	($1.86M)	($0.67M)	($0.70M)	($0.82M)	($1.71M)
Net Margin %(computed)	-348.16%	-13.98%	-20.12%	-46.27%	—
Per Share & EBITDA
EPS (Basic)	$-0.02	$-0.01	$-0.01	$-0.01	$-0.02
Wtd Avg Shares	101.29M	100.31M	99.56M	97.86M	92.61M
EBITDA	($1.23M)	($0.21M)	($0.28M)	($0.63M)	($1.64M)
EBITDA Margin %(computed)	-230.00%	-4.36%	-7.89%	-35.61%	—